Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Impact of a comprehensive intervention bundle implementing drug burden index as a clinical risk assessment tool on deprescribing anticholinergic and sedative drugs in older adults admitted to an Australian acute hospital: a pilot study

  • At: Seville (Spain) (2022)
  • Type: Poster
  • Poster code: HPS-037
  • By: FUJITA, Kenji (The University of Sydney, Kolling Institute, Australia)
  • Co-author(s): Dr Kenji Fujita, Postdoctoral Research Fellow (The University of Sydney, Kolling Institute, Sydney, Australia)
    Dr Nashwa Masnoon, Departments of Clinical Pharmacology and Aged Care (The University of Sydney, Kolling Institute, Sydney, Australia)
    Ms Sarita Lo, Departments of Clinical Pharmacology and Aged Care (The University of Sydney, Kolling Institute, Sydney, Australia)
    Patrick Hooper, eMR Connect Program (eMR Connect Program, eHealth NSW, Sydney, Australia)
    Dr. Sarah Hilmer, Departments of Clinical Pharmacology and Aged Care (The University of Sydney, Kolling Institute, Sydney, Australia)
  • Abstract:

    Background: The Drug Burden Index (DBI), a measure of total exposure to medications with anticholinergic and sedative effects, can identify patients at high risk of adverse drug events, who may benefit from deprescribing.

    Purpose: To evaluate the impact of a comprehensive intervention bundle using the DBI on i) the proportion of patients with at..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses